About this trial
This single-center observational prospective longitudinal study will assess cognitive, physical, and nutritional performance in acute leukemia patients undergoing intensive chemotherapy. Patients will provide informed consent prior to enrollment. Hematologists will oversee clinical management and approve evaluations, while physical and rehabilitation medicine specialists and a nutritionist will conduct assessments. Performance will be evaluated at admission, discharge, and three weeks (21 days) after starting chemotherapy.
Eligibility criteria
Qualifiers
Age above 18 years
Patients affected by Acute Leukemia
Inpatients performing intensive chemotherapy
Patients with no restrictions on mobilization
Disqualifiers
Age <18 years
Any medical condition that the attending doctor judges as limiting to perform study related tasks
Trial design
Treatments tested in this trial
- observational follow up aimed at evaluating functional, physical, cognitive, and nutritional parameters